XML 41 R30.htm IDEA: XBRL DOCUMENT v3.25.4
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2025
STOCK-BASED COMPENSATION  
Summary of the expense for stock-based compensation related to stock option grants

Twelve Months Ended

December 31, 

  ​ ​ ​

2025

  ​ ​ ​

2024

Employee and director stock option and stock grants:

  ​

  ​

Research and development

$

413,022

$

3,486,168

General and administrative

 

1,850,682

786,612

Total stock-based compensation

$

2,263,704

$

4,272,780

Schedule of assumptions used for stock

Year Ended December 31, 

 

  ​ ​ ​

2025

  ​ ​ ​

2024

 

Volatility

 

100.17

%  

82.13

%

Risk-free interest rate

 

4.37

%  

4.21-4.64

%

Expected life (years)

 

6.0

 

6.0

Dividend

 

0

%  

0

%

Summary of stock options activity

Number of

Shares

Issuable

Weighted

Upon

Average

Exercise

Weighted

Remaining

of

Average

Contracted

Aggregate

 

Outstanding

Exercise

 

Term in

Intrinsic

  ​ ​ ​

Options

  ​ ​ ​

Price

  ​ ​ ​

Years

  ​ ​ ​

Value

Outstanding as of December 31, 2023

 

78,397

$

163.80

 

8.64

 

$

1,682,667

Granted

 

102,116

$

81.60

 

 

  ​

Expired

 

(53)

$

600.00

 

 

  ​

Forfeited

 

(27,503)

$

75.30

 

 

  ​

Exercised

 

(55)

$

50.40

 

 

Outstanding as of December 31, 2024

152,902

$

123.00

7.37

$

Granted

77,331

$

8.70

Expired

(18,066)

$

125.25

Outstanding as of December 31, 2025

212,167

$

80.47

5.35

$

Exercisable as of December 31, 2025

 

113,080

$

129.93

 

$

Unvested as of December 31, 2025

 

99,087

$

24.03

 

$